BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15384941)

  • 1. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases.
    Azzouz M; Mazarakis N
    Curr Gene Ther; 2004 Sep; 4(3):277-86. PubMed ID: 15384941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.
    Teng Q; Garrity-Moses M; Federici T; Tanase D; Liu JK; Mazarakis ND; Azzouz M; Walmsley LE; Carlton E; Boulis NM
    Neurobiol Dis; 2005 Dec; 20(3):694-700. PubMed ID: 16005636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vectors for treating and modeling human CNS disorders.
    Azzouz M; Kingsman SM; Mazarakis ND
    J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy for ALS: progress and prospects.
    Azzouz M
    Biochim Biophys Acta; 2006; 1762(11-12):1122-7. PubMed ID: 16806843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction patterns of pseudotyped lentiviral vectors in the nervous system.
    Wong LF; Azzouz M; Walmsley LE; Askham Z; Wilkes FJ; Mitrophanous KA; Kingsman SM; Mazarakis ND
    Mol Ther; 2004 Jan; 9(1):101-11. PubMed ID: 14741783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and applications of non-HIV-based lentiviral vectors in neurological disorders.
    Valori CF; Ning K; Wyles M; Azzouz M
    Curr Gene Ther; 2008 Dec; 8(6):406-18. PubMed ID: 19075624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer.
    Federici T; Kutner R; Zhang XY; Kuroda H; Tordo N; Boulis NM; Reiser J
    Genet Vaccines Ther; 2009 Jan; 7():1. PubMed ID: 19144125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
    Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
    Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.
    Balaggan KS; Binley K; Esapa M; MacLaren RE; Iqball S; Duran Y; Pearson RA; Kan O; Barker SE; Smith AJ; Bainbridge JW; Naylor S; Ali RR
    Gene Ther; 2006 Aug; 13(15):1153-65. PubMed ID: 16572190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-based treatment of motor neuron diseases.
    Federici T; Boulis NM
    Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
    Azzouz M; Ralph S; Wong LF; Day D; Askham Z; Barber RD; Mitrophanous KA; Kingsman SM; Mazarakis ND
    Neuroreport; 2004 Apr; 15(6):985-90. PubMed ID: 15076720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
    Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
    Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors.
    Haase G; Kennel P; Pettmann B; Vigne E; Akli S; Revah F; Schmalbruch H; Kahn A
    Nat Med; 1997 Apr; 3(4):429-36. PubMed ID: 9095177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable gene transfer to the nervous system using a non-primate lentiviral vector.
    Mitrophanous K; Yoon S; Rohll J; Patil D; Wilkes F; Kim V; Kingsman S; Kingsman A; Mazarakis N
    Gene Ther; 1999 Nov; 6(11):1808-18. PubMed ID: 10602376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
    O'Rourke JP; Olsen JC; Bunnell BA
    Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
    Alisky JM; Davidson BL
    Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.
    O'Rourke JP; Newbound GC; Kohn DB; Olsen JC; Bunnell BA
    J Virol; 2002 Feb; 76(3):1510-5. PubMed ID: 11773424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
    Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
    J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
    Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
    Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.